TEL AVIV, Israel, August 23, 2011 /PRNewswire/ —
Elbit Imaging Ltd. (“EI“ or
the “Company“) (NASDAQ:
EMITF), announced today, in accordance with Section 4 of the
“Terms Behind the Page” of Series B Notes of the Company, that the
interest rate borne by Series B Notes for the interest period
beginning on August 21, 2011 and ending on February 21, 2012 is
1.56055%.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial and Entertainment Centers –
Initiation, construction and sale of shopping and entertainment
centers and other mixed-use real property projects, predominantly
in the retail sector, located in Central and Eastern Europe and in
India; (ii) U.S. Real Property – Investment in commercial
real property in the United States; (iii) Hotels – Hotel
operation and management, primarily in major European cities; (iv)
Medical Industries – (a) research and development,
production and marketing of magnetic resonance imaging guided
focused ultrasound treatment equipment and (b) development of stem
cell population expansion technologies and stem cell therapy
products for transplantation and regenerative medicine; (v)
Residential Projects – Initiation, construction and sale of
residential projects and other mixed-use real property projects,
predominately residential, located primarily in India and in
Eastern Europe; (vi) Fashion Apparel – Distribution and
marketing of fashion apparel and accessories in Israel; and (vii)
Other Activities – (a) venture capital investments and (b)
investments in hospitals and farm and dairy plants in India. We
have presently decided to suspend our investment activities in
hospitals and farm and dairy plants in India until we are satisfied
that the economy has recovered sufficiently to resume such
activities.
Any forward-looking st
‘/>”/>